Alshehri_2022_Evid.Based.Complement.Alternat.Med_2022_6726438

Reference

Title : Succinimide Derivatives as Antioxidant Anticholinesterases, Anti-alpha-Amylase, and Anti-alpha-Glucosidase: In Vitro and In Silico Approaches - Alshehri_2022_Evid.Based.Complement.Alternat.Med_2022_6726438
Author(s) : Alshehri OM , Mahnashi MH , Sadiq A , Zafar R , Jan MS , Ullah F , Alshehri MA , Alshamrani S , Hassan EE
Ref : Evid Based Complement Alternat Med , 2022 :6726438 , 2022
Abstract : Alshehri_2022_Evid.Based.Complement.Alternat.Med_2022_6726438
ESTHER : Alshehri_2022_Evid.Based.Complement.Alternat.Med_2022_6726438
PubMedSearch : Alshehri_2022_Evid.Based.Complement.Alternat.Med_2022_6726438
PubMedID: 35942378

Related information

Citations formats

Alshehri OM, Mahnashi MH, Sadiq A, Zafar R, Jan MS, Ullah F, Alshehri MA, Alshamrani S, Hassan EE (2022)
Succinimide Derivatives as Antioxidant Anticholinesterases, Anti-alpha-Amylase, and Anti-alpha-Glucosidase: In Vitro and In Silico Approaches
Evid Based Complement Alternat Med 2022 :6726438

Alshehri OM, Mahnashi MH, Sadiq A, Zafar R, Jan MS, Ullah F, Alshehri MA, Alshamrani S, Hassan EE (2022)
Evid Based Complement Alternat Med 2022 :6726438